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For many people, October in Minnesota signals
the arrival of costume parties and peak fall colors.
But for Vern Prososki and employees at St. Cloud–
based Collection Resources, it marks the opportu-
nity to bowl a few games and raise money for the
Bob Allison Ataxia Research Center (BAARC).
The company has held an annual bowl-a-thon to
benefit BAARC since 2001. For Prososki, co-owner
(with Phaen Waldron) of Collection Resources, the
decision to support BAARC was both professional
and personal.
“Our trade association, the American Collectors
Association, had developed a program for
encouraging involvement in philanthropy,”
recalls Prososki. “We decided to do
something, and this was the thing
that hit us close to home.”
That’s because ataxia had already
made its way into Prososki’s life.
Nearly 30 years ago, Prososki’s wife,
Ruth, was diagnosed with ataxia.
After initially receiving treatment in
St. Cloud, she learned of the University
of Minnesota Ataxia Center’s reputation in
ataxia management and soon started making the
hour-long drive to receive care in Minneapolis.
Last year 16 of the company’s 25 employees
participated in the bowl-a-thon, first generating
funds by seeking pledges from friends, neighbors,
and relatives, and then meeting their end of the
bargain by playing two games. Family members also
attended, and bumper bowling quickly became
a hit among the event’s youngest attendees.
This year’s event, held October 4, drew 22
bowlers and raised another $2,465 for ataxia
research at the University. That brings the
bowl-a-thon’s total raised to more than $22,000
for BAARC since the its inception.
To Prososki, the most rewarding part of the
event is witnessing the generosity that donors
exhibit year after year.
“It’s really nice to see people who have made
contributions annually,” he says. “It takes a big
commitment for them to step up to the plate like
that, time and again, especially with the tough
times that some people are going through these
days. Our hope is that we can continue to step up,
too, and hold this event for years to come.”
Rolling for ataxia research
Vern and Ruth
Prososki
Sometimes the beginning of a breakthrough happens on a short walk down the hall to a
colleague’s office. For ataxia researchers and other neuroscientists at the University of Minnesota,
whose offices may be scattered in buildings across campus, bouncing ideas off of one another in
person is not always so easy.
That will be changing soon, thanks to the 2006 Minnesota State Legislature’s decision to fund the
100,000-plus-square-foot Medical Biosciences Building (MBB), which is scheduled to be completed by
the end of 2009.
Most of the MBB will be devoted to the neurosciences and will include space for the N. Bud Grossman
Center for Memory Research and Care. The new building will house existing programs in neurodegen-
erative and neuromuscular diseases such as ataxia, muscular dystrophy, Parkinson’s, and ALS
(Lou Gehrig’s disease). The MBB also will house immunology research and be linked by skyway to the
University’s internationally renowned Center for Magnetic
Resonance Research (CMRR).
Lead ataxia researcher Harry Orr, Ph.D., says the
new building will create three key opportunities for
ataxia investigators and other neuroscientists. “It will
allow us to recruit new faculty in this area, it will
allow us to develop and access state-of-the-art core
facilities, and it will allow ataxia researchers and other
neuro-scientists to be in close proximity to one
another, which will synergize our research,” he says.
Assistant professor of laboratory medicine and
pathology Michael Koob, Ph.D., will soon join his
neuroscience colleagues in the new space but currently
is physically separated from them.
“It has really cut down on the spontaneous inter-
actions that would occur on a daily basis between
researchers who share lab space,” Koob says.
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The Medical Biosciences Building, scheduled
to open in fall 2009, is designed to foster
collaboration among neuroscience researchers.
“I expect that coming together as a research
community with shared interests and research
goals will result in a huge increase in the
number of collaborative projects our group is
able to pursue.”
Becoming one of the top public research
institutions in the nation remains an important
initiative for the University. The 2008 state
Legislature propelled the University a giant step
forward when it approved funding for four
additional state-of-the-art research buildings.
The five-year project, backed by university-sold
bonds, will cost $292 million and will provide
additional space for the CMRR and research in
infectious disease, cancer, and heart disease.
Neuromuscular disease researcher John Day,
M.D., Ph.D., believes that the new space will be a
valuable selling point for the 15 new neuroscience
investigators the University is hoping to recruit.
“One of the things a candidate may ask is, ‘Do
you have the space to do all the things you want
me to do?’ And we can honestly say yes,” says
Day, a professor of neurology and director of the
University’s Paul and Sheila Wellstone Muscular
Dystrophy Center. “Top-notch investigators will
be able to come in and right away have the
physical resources they need to contribute, and
that can give us the edge we need to maintain
our leadership in biomedical sciences research.”
Biosciences building continued from cover
Join us for this year’s Diamond Awards
The Diamond Awards, Minnesota’s premier baseball charity event, is back
for its fourth year of Twins baseball, philanthropy, and fun. Proceeds from
the Diamond Awards support the University of Minnesota’s innovative research and patient care in ataxia,
muscular dystrophy, multiple sclerosis, Parkinson’s, and ALS (Lou Gehrig’s disease).
This event, which will be held January 22, 2009, begins with a VIP reception with Minnesota Twins
players, followed by a general reception and silent auction. The evening culminates with dinner and a
televised awards ceremony, during which the Minnesota chapter of the Baseball Writers Association
of America honors contributions Twins players and coaches have made both on and off the field.
For tickets or more information on the Diamond Awards, visit www.minnesotadiamondawards.org
or contact Valerie Petermann at 612-624-4444 or v.petermann@mmf.umn.edu.
Golf tournament raises nearly $47,000—plus a match—
for ataxia research
The 7th annual Karen’s Hope Ataxia Benefit raised nearly $47,000 for the Bob Allison Ataxia
Research Center, which supports ataxia research and care efforts at the University of Minnesota.
In its history, the event has raised about $315,000 for this work.
This year longtime ataxia research supporter Connie Bakken matched the event’s proceeds
through the Whitney Arcee Foundation, making an even larger impact on the future of ataxia research.
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Looking forward to
the move are Michael
Koob, Ph.D. (front),
and his lab team of
(from left) Kellie
Benzow, Young Yoon,
Ph.D., and Yi-Wei
Yang, M.S.
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University
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grants
from
BAARC
Gülin Öz, Ph.D.
Long before it leads to loss of function, ataxia
causes changes in the brain that cannot be
detected through physical symptoms.
At first, biochemical changes to brain nerve
cells, or neurons, are small. Gradually, however,
they alter the metabolism of neurons and then
impair them. Left unchecked, these changes can
lead to the death of neurons and signal the
arrival of ataxia symptoms. And once neurons
die, their function never returns.
University of Minnesota ataxia researcher
Gülin Öz, Ph.D., is using magnetic resonance
spectroscopy (MRS) to try to detect cellular
changes before they cause irreversible damage.
Öz is looking beyond structural changes of the
cerebellum to explore the biochemical makeup
of this region of the brain.
Using high-field MRI scanners three to six
times stronger than those in most hospitals,
Öz is able to measure 18 chemicals found the
cerebellums of mice and up to 12 found in
human cerebellums and then detect alterations
in a subset of those chemicals that change with
disease. Monitoring these changes, says Öz, could
lead to earlier detection of ataxias and better
assessments of therapies in future clinical trials.
So far, Öz’s team has scanned people with
spinocerebellar ataxia (SCA) types 1, 2, 6,
Friedreich’s ataxia, ataxia with oculomotor
apraxia type 2, and multiple system atrophy and
has found different patterns of chemical
changes with these ataxias.
“In neurodegenerative diseases such as
ataxia, biochemical changes can occur years
before symptoms occur,” says Öz, an assistant
professor of radiology. “If we can intervene while
the dysfunction is occurring, then there’s a
chance that treatments can reverse any
alterations and rescue the cell.”
Thanks to seed money provided by the Bob
Allison Ataxia Research Center last year to get
this research off the ground, Öz recently
received funding from the National Institutes
of Health for two studies. The first study will
explore how MRS can help detect pre-ataxia
changes that occur in mice that are bred to have
SCA1. The second study will compare MRS brain
scans of people who have ataxia with brain scans
of people who do not have the condition—to
determine which biochemical changes can be
markers for ataxia’s presence.
Öz, who did her postdoctoral training at the
University’s renowned Center for Magnetic
Resonance Research before accepting a faculty
position here in 2006, says the University offers
a unique opportunity for research.
“Having the equipment is great, but it’s not
enough on its own,” she says. “You need the
expertise and support surrounding you, too, to
get the good science, the good data. All of that is
here. This is the best place to be doing research
on neurodegenerative diseases.”
The Bob Allison Ataxia Research Center’s board of directors has awarded a total of $225,000 to
three University of Minnesota ataxia investigators. Each grant provides seed funding that allows
these researchers to test their new ideas about how to better diagnose, treat, or prevent ataxia.
Michael D. Koob, Ph.D., assistant professor in the Department of Laboratory Medicine and Pathology,
received a $75,000 grant to start developing a gene therapy to treat Friedreich’s ataxia.
Ramaiah Muthyala, Ph.D., associate professor in the College of Pharmacy, received a $75,000 grant to
develop novel therapeutics for spinocerebellar ataxia type 1.
Laura Ranum, Ph.D., professor in the Department of Genetics, Cell Biology, and Development, received a
$75,000 grant to investigate the role of spectrin and interacting proteins in sporadic and familial ataxia.
Catching a chemical before it does damage
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